Guan, Xin-Yuan

No ORCID on file · 1 paper in corpus · active 2016

Study types

  • other 1
other 2016
·doi:10.6084/m9.figshare.c.3621974

Abstract Background Hepatocellular carcinoma (HCC) is one of the most fatal malignancies worldwide, and CD133 is a popular cancer stem cell (CSC) marker for HCC. CD133+ CSCs have been reported to resist conventional chemo- and radiotherapy,…